Cystic Fibrosis Trial, Recruiting NCT06216704 Sponsor: Massachusetts General Hospital Condition: Cystic Fibrosis
Back to Cystic Fibrosis

Cystic Fibrosis Trial, Recruiting

NCT06216704
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 13 and 20 years old
  • You have cystic fibrosis with pancreatic insufficiency (meaning your pancreas does not produce enough digestive enzymes)
  • Your treatment plan, including any CFTR modulator medications, has stayed the same for the past three months
  • If you have had a liver transplant, you may still be eligible as long as it was at least one year ago and you are no longer taking Prednisone to prevent organ rejection

Who may not be able to join:

  • You have another long-term condition that is known to affect bone health
  • You have taken medications known to affect bone health or bone development within the past three months
  • You have had a cystic fibrosis flare-up, or taken steroid medications (such as Prednisone or similar drugs), within the past month
  • You have had a lung transplant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rebecca Gordon, MD, Boston Children's Hospital

Phone: (617) 355-7476

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
31 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Bone marrow adiposity by magnetic resonance relaxometry (MR relaxometry); Bone marrow adiposity by magnetic resonance spectroscopy (MRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov